Loading organizations...
ZetrOZ Systems develops and manufactures non-invasive medical devices focused on accelerating tissue healing and providing pain relief. Their flagship product, the sam® wearable ultrasound device, utilizes sustained acoustic medicine to deliver continuous, low-intensity ultrasound therapy. This drug-free technology penetrates deep into soft tissue to increase circulation and facilitate healing, offering an alternative for managing chronic pain and injury.
The company was founded in 2009, with Dr. George K. Lewis, a biomedical engineer, serving as a key co-founder, Chief Science Officer, and CEO. His foundational insight centered on transforming the application of ultrasound technology into a portable, user-friendly format, addressing a significant need for accessible and effective therapeutic solutions outside traditional clinical settings. This approach aimed to make advanced healing technologies readily available.
ZetrOZ serves a diverse customer base, including individuals experiencing soft tissue injuries, arthritis, and chronic pain, as well as athletes seeking enhanced recovery and injury prevention. The company envisions itself as a global leader in its specialized field, continually advancing its proprietary technology to expand worldwide access to its innovative solutions for pain management and restorative health.
ZetrOZ has raised $10.0M across 3 funding rounds.
ZetrOZ has raised $10.0M in total across 3 funding rounds.
ZetrOZ is a medical‑technology company that develops wearable, drug‑free, non‑invasive ultrasound devices (branded sam®) designed to deliver long‑duration, low‑intensity therapeutic ultrasound to accelerate healing and reduce pain in musculoskeletal conditions[1][5].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech & Healthcare Landscape
Quick Take & Future Outlook
Sources: ZetrOZ corporate site and technology pages[1], CB Insights company profile[2], industry coverage and press releases[3][5], and SBIR project summaries[4].
ZetrOZ has raised $10.0M across 3 funding rounds. Most recently, it raised $5.0M Debt in October 2014.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 19, 2014 | $5M Debt Financing | Jerry Michaud | — | Announced |
| Jun 26, 2014 | $2M Venture Round | — | Angel Investor Forum, Boston Harbor Angels, Connecticut Innovations, Launchpad Venture Group, Mass Medical Angels, Standard OIL Ventures | Announced |
| Apr 1, 2013 | $3M Series A | Connecticut Innovations | Crosscut Ventures, Standard OIL Ventures | Announced |
ZetrOZ has raised $10.0M in total across 3 funding rounds.
ZetrOZ's investors include Jerry Michaud, Angel Investor Forum, Boston Harbor Angels, Connecticut Innovations, Launchpad Venture Group, Mass Medical Angels, Standard Oil Ventures, Crosscut Ventures.